Method for reducing adenosine levels with a dehydroepiandrosterone and optionally a ubiquinone
US6087351A · kind A · utility
64Cited by
29References
72Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 22, 1997 |
| Grant date | Jul 11, 2000 |
| Priority date | — |
| Expiry date | May 22, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method and composition for reducing adenosine levels comprises administering a dehydroepiandrosterone, and optionally a ubiquinone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.